30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DiscGenics Entering Clinical Trial in Japan for Disc Cell Therapy -

DiscGenics received approval in Japan to advance into clinical studies of IDCT allogeneic injectible disc cell therapy for the treatment of lumbar degenerative disc disease. The prospective, double-blinded, sham-controlled, multicenter study will evaluate the safety and preliminary efficacy of IDCT in Japanese patients. The 38-patient trial is slated to begin enrollment in 1H19. (DiscGenics, Inc., 12/11/18)